Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer

Immune checkpoint inhibitor (ICI)‐based immunotherapy brought new hope for gastric cancer (GC) treatment. However, due to the lack of proper biomarkers, patient selection and outcome prediction for GC's immunotherapy remain unsatisfying. In this study, through applying an extracellular vesicle...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cheng, Chong, Xiaoyi, Jiang, Fangli, Gao, Jing, Chen, Yang, Jia, Keren, Fan, Meng, Liu, Xuan, An, Jin, Li, Jian, Zhang, Xiaotian, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971562/
https://www.ncbi.nlm.nih.gov/pubmed/35362262
http://dx.doi.org/10.1002/jev2.12209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971562/
https://www.ncbi.nlm.nih.gov/pubmed/35362262
http://dx.doi.org/10.1002/jev2.12209

Ejemplares similares